Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Income

v3.3.1.900
Consolidated Statements of Operations and Comprehensive Income - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Revenues:    
Product Revenue $ 1,757,982 $ 2,453,462
Product Revenue - Related parties 36,512 1,630,379
License Revenue 15,000 10,000
License Revenue - Related party 305,556 333,333
Total Revenues 2,115,050 4,427,174
Cost of Sales:    
Product Cost of Sales (950,792) (1,175,232)
Gross Profit 1,164,258 3,251,942
Administrative Expenses 4,029,515 3,784,078
Administrative Expenses - Related parties 2,163,610 195,002
Sales and Marketing Expenses 2,543,286 1,302,103
Research and Development Expenses 1,406,895 $ 916,308
Impairment of Non-Current Assets 466,476
Amortization of Non-Current Assets 236,706 $ 258,572
Loss from Operations (9,682,230) (3,204,121)
Other (Income)/Expenses    
Foreign Currency Transaction (Gain)/Loss 7,535 (2,667)
Gain from demutualization of insurance carrier (6,052) (4,669)
Interest and Dividend Income (102,456) (69,618)
Total Other Income (100,973) (76,954)
Loss Before Income Taxes (9,311,913) $ (3,127,167)
Income Tax Benefit $ 269,344
Preferred Stock Dividend $ (15,793)
Net Loss Attributable to Common Stockholders $ (9,311,913) (3,142,960)
Other Comprehensive Income/(Loss)    
Unrealized Gains/(Losses) on Marketable Securities 13,893 (20,124)
Total Other Comprehensive Income/(Loss) 13,893 (20,124)
Comprehensive Loss $ (9,298,020) $ (3,163,084)
Basic & diluted loss per common share $ (1.81) $ (0.66)
Weighted average basic & diluted common shares outstanding 5,140,920 4,745,684